tomisaku
kawasaki
describ
clinic
featur
new
ill
call
mucocutan
lymph
node
syndrom
diseas
present
small
percentag
sudden
death
often
took
place
week
fever
death
result
thrombot
occlus
coronari
arteri
aneurysm
ruptur
occur
fatal
current
diseas
refer
kawasaki
diseas
kd
known
predominantli
affect
young
children
case
occur
month
year
male
predomin
approxim
time
common
incid
kd
vari
consider
ethnic
group
north
east
asia
time
higher
caucasia
highest
incid
report
japan
recent
studi
kd
epidemiolog
point
rapidli
industri
countri
china
india
diseas
may
replac
rheumat
heart
diseas
common
caus
acquir
heart
diseas
children
instead
western
australia
kd
epidemiolog
similar
europeancaucasian
popul
etiopathogenesi
kd
yet
identifi
caus
infecti
agent
environment
toxin
genet
factor
superantigen
caus
nonspecif
activ
cell
progress
improv
knowledg
pathogenesi
diseas
recent
achiev
review
report
recent
data
suggest
scenario
dysregul
plateletleucocyt
interact
thelper
type
regulatori
cell
reg
may
function
immunolog
inflammatori
amplifi
result
defect
inflamm
resolut
kd
patient
state
although
year
pass
first
descript
exact
etiopathogenesi
kd
remain
unknown
clinic
epidemiolog
line
evid
support
implic
infecti
agent
patholog
studi
propos
acut
coronari
arter
follow
heal
fail
account
complex
vasculopathi
clinic
cours
kd
addit
advanc
molecular
genet
analysi
complet
human
genom
project
led
identifi
gene
associ
kd
find
discuss
rowley
collabor
reveal
presenc
mark
iga
plasma
cell
respons
acut
kd
tissu
suggest
specif
immun
respons
potenti
direct
antigen
suggest
involv
diseas
etiopathogenesi
inde
use
synthet
antibodi
deriv
oligoclon
iga
gene
sequenc
identifi
intracytoplasm
inclus
bodi
viruslik
particl
intact
tissu
section
children
kd
specif
ciliat
epithelium
mediums
bronchi
studi
suggest
therefor
put
viral
aetiolog
agent
caus
system
vascul
kd
patient
moreov
patholog
studi
identifi
three
distinct
link
basic
kd
vascular
process
necrot
arter
subacut
chronic
vascul
lumin
myofibroblast
prolifer
necrot
arter
acut
synchron
neutrophil
process
mediums
arteri
could
respons
saccular
aneurysm
lead
format
thrombi
ruptur
within
first
month
start
endothelium
mediums
muscular
elast
arteri
progress
peripher
lumin
myofibroblast
prolifer
occur
close
associ
subacut
chronic
vascul
uniqu
process
involv
medial
smooth
muscl
cellderiv
myofibroblast
matrix
product
form
concentr
mass
progress
obstruct
arteri
lumen
subacut
chronic
vascul
lumin
myofibroblast
prolifer
persist
month
year
follow
onset
kd
furthermor
giant
aneurysm
like
develop
stenosi
result
repetit
layer
thrombi
eventu
becom
occlus
wherea
dilat
coronari
arteri
preserv
portion
media
like
undergo
lumin
myofibroblast
prolifer
without
thrombosi
insight
could
deriv
studi
haematolog
featur
encount
patient
instanc
format
heterotyp
plateletleucocyt
aggreg
depend
platelet
activ
rule
leucocyterbcplatelet
aggreg
could
least
partial
associ
releas
proaggreg
factor
eg
arachidon
andor
chang
cell
surfac
molecul
express
includ
pselectin
crosstalk
activ
platelet
leucocyt
oper
sever
system
includ
interact
pselectin
pselectin
glycoprotein
pselectin
vascular
adhes
molecul
play
import
role
inflammatori
respons
mediat
interact
leucocyt
stimul
endothelium
platelet
bound
vicin
vascular
injuri
pselectin
captur
leucocyt
blood
bring
contact
endotheli
cell
surfac
blood
vessel
wall
interact
support
leucocyt
roll
hand
neutrophil
interact
adher
platelet
leucocyt
process
call
secondari
captur
often
follow
neutrophilendotheli
interact
inflamm
neutrophil
recruit
platelet
contribut
tolllik
receptor
neutrophil
extracellular
trap
net
format
function
baromet
system
infect
importantli
platelet
stimul
net
format
net
caus
platelet
activ
aggreg
thu
link
inflamm
thrombosi
occurr
circul
plateletneutrophil
aggreg
alter
fibrinogen
cascad
content
previous
observ
patient
kd
seem
support
relev
mechan
pathogenesi
diseas
decad
kd
research
attempt
identifi
candid
gene
confer
suscept
ill
particular
gene
relat
innat
acquir
immun
function
vascular
remodel
studi
although
incid
kd
vari
differ
ethnic
popul
genet
polymorph
c
itpkc
caspas
shown
associ
coronari
arteri
lesion
format
japanes
taiwanes
popul
patient
kd
itpkc
gene
locat
chromosom
act
neg
regul
tcell
activ
gene
locat
chromosom
profoundli
relat
apoptosi
immun
cell
itpkc
involv
ca
nuclear
factor
activ
tcell
pathway
indic
potenti
role
signal
pathway
immun
system
furthermor
shimizu
et
al
suggest
genet
variat
transform
growth
factorb
tgfb
signal
pathway
influenc
suscept
manifest
kd
diseas
outcom
well
respons
therapi
immun
system
tgfb
modul
balanc
proinflammatoryantiinflammatori
cell
complex
set
interact
genet
variat
tgfb
pathway
may
lead
imbal
proinflammatori
regulatori
cell
reg
affect
express
forkheadwing
helix
transcript
factor
involv
differenti
function
surviv
regulatori
cell
intern
kawasaki
diseas
genet
consortium
perform
replic
studi
popul
korean
european
descent
confirm
genet
contribut
kd
pathogenesi
find
associ
blymphoid
tyrosin
kinas
blk
gene
kd
blk
src
famili
tyrosin
kinas
express
primarili
bcell
lineag
locat
chromosom
express
pattern
acut
convalesc
stage
kd
correl
percentag
b
cell
peripher
blood
mononuclear
cell
moreov
hsueh
et
al
report
associ
interleukin
il
promot
polymorph
posit
allel
kd
suscept
taiwanes
patient
popul
locat
chromosom
potent
cytokin
exert
pleiotrop
effect
immunoregul
inflamm
associ
genet
polymorph
coronari
arteri
aneurysm
taiwanes
kd
patient
found
sever
evid
suggest
genet
determin
could
contribut
pathogenesi
progress
kd
relationship
found
interleukin
polymorph
initi
ivig
treatment
failur
kd
children
ii
find
gene
member
kcnn
famili
potassium
channel
gene
locat
chromosom
could
role
new
risk
locu
coronari
aneurysm
iii
genomewid
associ
studi
suggest
gene
encod
lowaffin
immunoglobulin
gamma
fc
region
receptor
iia
protein
suscept
locu
kd
onset
final
iv
hypothesi
genet
variat
human
leucocyt
antigen
hla
killer
immunoglobulinlik
receptor
kir
loci
could
exert
modulatori
activ
either
individu
combin
hlakir
epistasi
candid
gene
etiopathogenesi
kd
list
tabl
activ
immun
system
cascad
inflammatori
factor
consid
import
featur
kd
larg
number
cell
mononuclear
cell
macrophag
plasma
cell
smaller
number
neutrophil
observ
variou
organ
tissu
fatal
case
acut
kd
imbal
subset
acut
stage
kd
suggest
matsubara
et
al
particular
decreas
number
produc
interferon
ifn
c
produc
observ
gener
rule
cell
play
import
role
cellular
immun
secret
ifnc
wherea
cell
helper
function
develop
antibodyproduc
b
cell
secret
variou
cytokin
cytokin
play
import
role
progress
system
activ
immun
system
local
inflamm
coronari
vessel
recent
demonstr
kd
patient
may
nonrespons
ivig
ivig
treatment
serum
level
decreas
slowli
level
tnfa
increas
import
also
data
obtain
studi
reg
cell
cell
describ
two
subset
distinct
cell
cell
long
known
regul
cellular
humour
immun
cell
identifi
recent
th
lineag
regul
inflamm
via
product
distinct
cytokin
interleukin
convers
reg
cell
express
antiinflammatori
role
maintain
toler
selfcompon
contactdepend
suppress
releas
antiinflammatori
cytokin
eg
imbal
reg
cell
describ
peripher
blood
patient
kd
interestingli
ikeda
collabor
report
acut
phase
peripher
blood
mononuclear
cell
kd
patient
show
uniqu
activ
state
high
express
gene
damageassoci
molecular
pattern
molecul
low
express
proinflammatori
cytokin
gene
sever
studi
point
role
growth
factor
pathogenesi
kd
exampl
tgfb
signal
suggest
contribut
induct
reg
aneurysm
format
promot
gener
myofibroblast
cell
could
mediat
damag
arteri
wall
recruit
proinflammatori
cell
furthermor
also
hepatocyt
growth
factor
togeth
vegf
might
play
import
role
serum
level
could
power
predictor
develop
coronari
arteri
lesion
kd
must
howev
stress
although
kd
sure
character
mark
activ
immun
system
elev
serum
proinflammatori
cytokin
chemokin
mainli
acut
phase
major
sourc
chemic
mediat
remain
yet
controversi
cell
involv
kd
pathogenesi
progress
list
tabl
although
still
controversi
possibl
involv
superantigen
pathogenesi
kd
suggest
staphylococc
streptococc
superantigen
propos
aetiolog
agent
pathogenesi
diseas
superantigen
extracellular
protein
toxin
whose
properti
includ
pyrogen
mitogen
activ
specif
tcell
subset
abil
increas
host
suscept
endotox
shock
suppress
immunoglobulin
multipl
studi
shown
involv
variabl
region
beta
chain
cell
patient
acut
kd
increas
antistreptococc
pyrogen
exotoxin
type
c
spec
antibodi
found
sera
kd
patient
acut
phase
yoshioka
et
al
moreov
increas
antispec
spea
igm
first
week
follow
ill
found
matsubara
et
al
howev
despit
evid
serolog
studi
found
signific
differ
superantigen
antibodi
number
viral
agent
also
found
blood
patient
kd
eg
coronaviru
hcov
suggest
exert
pathogenet
role
review
see
refer
howev
definit
conclus
drawn
concern
specif
associ
agent
kd
onset
progress
fact
import
studi
demonstr
presenc
infecti
agent
affect
efficaci
ivig
treatment
well
cardiovascular
outcom
presenc
infecti
agent
could
instead
ignit
imbal
immun
system
lead
hyperimmun
reaction
occur
patient
kd
studi
carri
peripher
blood
patient
kd
provid
huge
seri
data
relev
clinic
practic
identifi
number
possibl
biomark
diseas
onset
progress
among
biomark
inflamm
erythrocyt
sediment
rate
creactiv
protein
haptoglobin
white
blood
cell
count
fibrinogenrel
protein
clusterin
ntermin
prohormon
brain
natriuret
peptid
ntprobnp
cardiac
troponin
creatinin
kinas
identifi
import
ntprobnp
recent
reassess
level
prohormon
rais
symptomat
asymptomat
patient
lv
dysfunct
allow
specif
biomark
kd
patient
investig
detail
final
genet
polymorph
also
consid
potenti
biomark
kd
particular
regard
six
hla
class
gene
two
mhc
class
chainrel
gene
mica
allel
itpkc
gene
oxid
stress
link
inflamm
character
diseas
recent
includ
among
potenti
use
diagnost
biomark
vasculatur
kd
particular
chang
serum
redox
state
increas
express
induc
nitric
oxid
synthas
no
monocytesneutrophil
well
tabl
regul
cellular
immun
secret
ifnc
downregul
regul
humour
immun
secret
involv
respons
ivig
treatment
regul
inflamm
secret
upregul
reg
antiinflammatori
role
releas
downregul
reg
regulatori
cell
elev
concentr
plasma
nitric
oxid
found
kd
patient
fact
oxidativenitr
stress
measur
kd
inflam
blood
vessel
reveal
high
level
reactiv
oxid
speci
ie
superoxid
anion
nitric
oxid
protein
mpo
level
blood
protein
coval
posttransl
modif
identifi
format
nitric
oxidederiv
nitrat
agent
use
specif
biomark
oxid
burden
mani
patholog
condit
acut
chronic
diseas
increas
level
mpo
proinflammatori
enzym
releas
activ
leucocyt
could
support
proinflammatori
statu
form
highli
oxid
speci
protein
oxid
product
promot
lipid
peroxid
induc
autoimmun
respons
mediat
mpo
autoantibodi
moreov
mpo
could
promot
procoagul
state
blood
although
bind
platelet
neutrophil
surfac
favour
appear
plateletneutrophil
aggreg
detect
kd
regard
mpo
could
play
pathogenet
role
cardiovascular
complic
kd
could
consid
biomark
inflamm
diseas
furthermor
suggest
prooxid
blood
statu
could
alter
also
red
blood
cell
rbc
homeostasi
result
sort
prematur
age
circul
cell
could
lead
anaemia
format
blood
clot
particular
decreas
glycophorin
express
well
extern
phosphatidylserin
ps
measur
rbc
kd
patient
glycophorin
glycoprotein
wide
express
rbc
surfac
downregul
cell
senesc
integrinassoci
protein
known
thrombospondin
receptor
act
marker
self
ps
phospholipid
normal
local
inner
leaflet
plasma
membran
extern
outer
leaflet
cell
remodel
lead
rbc
age
cell
death
appear
age
death
biomark
rbc
kd
patient
relat
clinic
evalu
inde
first
day
hospit
number
rbc
valu
haemoglobin
mean
corpuscular
volum
haematocrit
significantli
decreas
kd
patient
could
relev
rbc
act
physiolog
scaveng
ro
circul
blood
consid
biosensor
monitor
oxid
imbal
inflammatori
diseas
importantli
alter
rbc
structur
function
may
independ
synergist
impair
blood
flow
induc
vascular
occlus
wherea
prematur
age
rbc
consequ
remov
circul
might
risk
factor
anaemia
vascular
occlus
anaemia
patholog
condit
found
kd
patient
patient
kd
also
experi
number
haematolog
abnorm
acut
phase
diseas
thrombocytosi
often
observ
exert
pathogenet
role
cardiovascular
complic
character
kd
recent
suggest
thrombocytosi
kd
could
depend
platelet
stimul
defect
apoptosi
probabl
bolster
nitros
stress
hypothesi
support
detect
circul
plateletsneutrophil
aggreg
kd
patient
increas
marker
platelet
activ
shed
pselectin
extern
ps
pselectin
celladhes
molecul
constitut
express
agranul
rest
platelet
transloc
surfac
platelet
activ
releas
shed
phenomenon
modul
leucocyt
adhes
platelet
endotheli
cell
inflammatori
respons
thrombu
format
extern
ps
platelet
ie
presenc
outer
leaflet
plasma
membran
usual
associ
sort
program
cell
death
also
correl
hyperactiv
importantli
specif
studi
platelet
activ
identifi
two
differ
platelet
subpopul
peripher
blood
na
patient
kd
platelet
ps
extern
annexin
v
posit
platelet
character
loss
mitochondri
membran
potenti
consid
procoagul
ii
platelet
without
ps
extern
annexin
v
neg
platelet
character
mitochondri
membran
hyperpolar
latter
subpopul
becom
procoagul
stimul
mediat
normal
releas
activ
platelet
eg
adenosin
diphosph
two
subpopul
may
consider
affect
coagul
cascad
inflammatori
respons
kd
patient
signific
alter
also
detect
plasma
kd
patient
decreas
antioxid
power
ii
decreas
level
asymmetr
dymethylarginin
adma
iii
increas
level
solubl
pselectin
solubl
annexin
v
increas
level
adma
specif
endogen
inhibitor
endotheli
no
induc
dysfunct
endothelium
becom
clinic
evid
impair
endotheliumdepend
vasodil
hyperaggreg
platelet
enhanc
monocyt
adhes
solubl
pselectin
celladhes
molecul
consid
marker
vivo
platelet
activ
associ
thrombu
growth
solubl
annexin
v
releas
endotheli
cell
platelet
calciumdepend
protein
activ
base
phosphatidylserin
bind
includ
membran
damag
repair
peripher
blood
diagnost
prognost
biomark
list
tabl
rare
diseas
evalu
kd
pathogenesi
extrem
complex
deepli
affect
small
number
patient
small
sampl
size
biolog
sampl
peculiar
affect
patient
infant
children
collect
limit
laboratori
data
well
lack
multicent
collabor
addit
kd
patient
share
featur
eg
inflammatori
marker
sever
chronic
acut
diseas
consequ
absenc
pathognomon
laboratori
test
allow
diagnosi
kd
depend
almost
exclus
recognit
clinic
criteria
slow
often
lose
chanc
monitor
identifi
suitabl
kd
pathogenet
determin
undertaken
optim
kd
clinic
diagnosi
base
corrobor
laboratori
data
allow
compil
univers
suitabl
guidelin
laboratori
analys
could
allow
earlier
focus
diagnosi
prompt
treatment
also
improv
appropri
cure
aim
could
reach
support
stringent
clinic
surveil
ii
creat
multicent
clinic
network
facilit
enrol
patient
uncommon
diseas
effici
test
new
therapi
aim
prevent
diseas
progress
iii
creat
databas
registri
longterm
followup
kd
patient
iv
improv
clinic
studi
aim
discov
aetiolog
kd
v
deciph
genet
influenc
diseas
suscept
outcom
review
show
complex
framework
event
contribut
etiopathogenesi
kd
includ
type
bacteri
viral
infect
genet
determin
immun
system
well
haematolog
alter
altogeth
factor
play
role
onset
progress
diseas
fact
determin
act
synergist
could
give
rise
diseas
addit
also
consid
use
tool
diagnost
prognost
purpos
henc
least
haematolog
manifest
kd
concern
far
understand
complex
intertwin
cellular
molecular
crosstalk
lead
cardiovascular
risk
patient
furthermor
scenario
genet
predisposit
seem
repres
key
background
capabl
impact
clinic
outcom
kd
